Abstract
Context: Primary hyperparathyroidism occurs in almost all patients with the syndrome of multiple endocrine neoplasia type 1 (MEN1), but the association of MEN1 with parathyroid carcinoma has only been described previously in a single patient. In this report, we describe two further cases of parathyroid carcinoma presenting in MEN1 syndrome. Case reports: The first patient was a 69-yr-old woman, who presented with severe primary hyperparathyroidism and tracheal compression by a large mediastinal mass, which was shown histologically to be a parathyroid carcinoma with a second similar lesion in the neck. She was treated with total parathyroidectomy followed by resection of the mediastinal mass with resolution of the hypercalemia. Remarkably, she also reported primary amenorrhea and was found to have an invasive pituitary lactotroph adenoma, which was treated with cabergoline and external beam radiotherapy. Magnetic resonance imaging (MRI) of the pancreas revealed a small lesion characteristic of an islet-cell tumor, which was clinically and biochemically non-functioning. The second patient was a 32-yr-old man who presented with symptomatic hypercalemia and markedly raised serum PTH concentration. Neck exploration revealed two parathyroid glands only. One of the parathyroid glands contained a tumor with fibrous banding, atypical mitoses, extra-capsular extension and moderate Ki 67 staining; features which are highly suggestive of carcinoma. He also had intractable dyspepsia associated with raised serum gastrin concentration. A lesion was localized to the neck of the pancreas by endocopic ultrasound, and a selective arterial calcium stimulation catheter suggested the presence of both a gastrinoma and an insulinoma, although he had no hypoglycemic symptoms. Pituitary MRI was normal. The patient’s mother had primary hyperparathyroidism. Conclusions: This case report describes two further patients in whom parathyroid carcinomas occurred in the context of MEN1, which gives a new insight to the possible presenting phenotype of this condition. Both patients had negative genetic screening for classic MEN1 gene mutation, which may suggest that one or more novel occult mutations may be responsible for this aggressive phenotype.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86: 5658–71.
Marx SJ. Multiple endocrine neoplasia type 1. In: Scriver CR, Beaudet AL, Sly WS, Valle D eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. 2001, 943–66.
Skogseid B, Oberg K, Eriksson B, et al. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 1996, 20: 872–7.
Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA. Familial multiple endocrine neoplasia type 1: a new look at pathophysiology. Endocr Rev 1987, 4: 391–405.
Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MENI). Q J Med 1996, 89: 653–69.
Skarulis MC. Clinical expressions of multiple endocrine neoplasia type 1 at the National Institutes of Health. Ann Intern Med 1998, 129: 484–94.
Shane E. Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab 2001, 86: 485–93.
Dionisi S, Minisola S, Pepe J, et al. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc 2002, 77: 866–9.
Schantz A, Castleman B. Parathyroid carcinoma: a study of 70 cases. Cancer 1973, 31: 600–5.
Bondeson L, Grimelius L, DeLellis RA. Parathyroid carcinoma. In DeLellis RA, Lloyd RV, Heitz PU, Eng C eds. WHO classification of tumours, pathology and genetics: tumours of the endocrine organs. Lyon: IARC Press. 2004, 124–7.
Sato M, Miyauchi A, Namihira H, et al. A newly recognised germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma. Endocrine 2000, 12: 223–6.
Jenkins PJ, Satta MA, Simmgen M, et al. Metastatic parathyroid carcinoma in the MEN2A syndrome. Clin Endocrinol (Oxf) 1997, 47: 747–51.
Uchino S, Noguchi S, Sato M, et al. Screening of the MEN1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 2000, 60: 5553–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agha, A., Carpenter, R., Bhattacharya, S. et al. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: Two case reports of an unrecognised entity. J Endocrinol Invest 30, 145–149 (2007). https://doi.org/10.1007/BF03347413
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347413